CALCA and migraine disorder: Despite the potential of the novel anti-migraine drugs to decrease the inotropic effects of CGRP, most patients will probably not notice any cardiac effects, as the physiological CGRP concentrations are probably not sufficient to induce a positive inotropic effect without pre-stimulation.